JAK Inhibitors for Type 1 Diabetes: Research, Treatment, and Results
2023-12-07 03:31:54 The possibility has been suggested that Janus kinase (JAK) inhibitors, which are used for rheumatoid arthritis and atopic dermatitis as a mechanism to control immunity and inflammation, can also be used for type 1 diabetes. Type 1 diabetes is caused by the destruction of pancreatic beta cells due to an autoimmune reaction, so … Read more